latest news releases from the newsroom
Autoliv buys German licensee
STOCKHOLM, Sweden, July 28, 2003 (PRIMEZONE) -- Autoliv Inc. (NYSE:ALV), the worldwide leader in automotive safety systems -- has agreed to buy the German seat belt company Protektor, which specializes in seat belts for niche markets, such as seat belts for buses, heavy trucks, forklifts, agricultural vehicles and other special-purpose vehicles. Autoliv is the world's largest supplier of seat belts for the original equipment market for passenger cars and other light vehicles. Protektor sells in 20 countries. Exports account for 35% of the company's Euro 10 million in turnover.
Old Mutual plc
Old Mutual Asset Management Reports Results for the 2Q 2003
LONDON, and BOSTON, July 28, 2003 (PRIMEZONE) -- Old Mutual Asset Management, the U.S. asset management group of Old Mutual plc (Other OTC:ODMTF) (LSE:OML), today announced results for its member firms for the second quarter of 2003. Assets under management for the group increased by 12.0% overall, with investment performance accounting for 10.8% of the gain and the remainder attributed to combined net inflows of client assets of $1.4 billion, or 1.2% of March 31 assets of $121.5 billion. As of June 30, 2003, Old Mutual Asset Management member firms managed a total of $136.1 billion."The benefits of our diversified structure are most evident when markets experience a dramatic shift in sentiment, as we saw from the first to the second quarters this year," said Scott Powers, chief executive of Old Mutual Asset Management. "Our firms have succeeded by remaining committed to their investment disciplines and providing clients with the focused expertise and specific market exposure they require."
Amersham PLC appoints Prof. James E. Rothman as Chief Scientific Adviser
BUCKINGHAMSHIRE, U.K., July 28, 2003 (PRIMEZONE) -- Amersham plc (LSE:AHM) (NYSE:AHM) (OSE:AHM) announced today the appointment of Professor James E. Rothman to the newly-created position of Chief Scientific Adviser, following seven years of service on Amersham's Scientific Advisory Board. Professor Rothman will work with the Chief Executive, Sir William Castell, and will sit on Amersham's Portfolio Committee, which has primary responsibility for recommending the overall strategic direction of the company's research.Professor Rothman, currently Chairman of the Cellular Biochemistry and Biophysics Program at Memorial Sloan-Kettering Cancer Center in New York, is one of the world's most distinguished biochemists and cell biologists. Recently, Columbia University in New York announced that Professor Rothman will join the faculty of the Department of Physiology at the College of Physicians and Surgeons, where he will found the Center for Chemical Biology.
F. Hoffmann-La Roche AG
Bondronat for treatment of Metastatic Bone Disease Clears Important Regulatory Hurdle in Europe
BASEL, Switzerland, July 28, 2003 (PRIMEZONE) -- Roche announced today that the European CPMP has issued a positive opinion for the use of oral and intravenous Bondronat (ibandronate) "prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases". The CPMP is the advisory board of the European Agency for the Evaluation of Medicinal Products (EMEA) and a positive opinion is generally considered a recommendation for formal European Commission approval. This will be an additional major indication for Bondronat which is currently used to treat hypercalcaemia of malignancy. This indication significantly increases the number of cancer patients who can benefit from Bondronat.
Ahold announces further personnel changes
ZAANDAM, Netherlands, July 28, 2003 (PRIMEZONE) -- Ahold (NYSE:AHO) (Amsterdam:AHLN) today announced that Jan Hommen, Vice Chairman and Finance Director of Royal Philips and a member of Ahold's Supervisory Board, was recently appointed as Chairman of Ahold's Audit Committee. This appointment, as well as the recent appointment of Anders Moberg as acting Chief Executive Officer of Ahold, will allow Henny de Ruiter to focus his attention on his duties as Chairman of Ahold's Supervisory Board, whilst continuing to serve as a member of the Audit Committee.
Trintech Group Plc
Thermae Bath Spa Selects Trintech's Industry-Leading PayWare Merchant to Provide Fast and Secure Card Payments; UK's New Prestigious Hot Spa Development Selects Trintech's Bank-Accredited Merchant Payment Solution that is Fully EMV Chip and PIN Ready
LONDON and DALLAS, Texas, July 28, 2003 - Trintech Group Plc (Nasdaq:TTPA) (Prime Standard:TTP), a leading provider of transaction management and payment infrastructure solutions, today announced that Thermae Bath Spa, the UK's only rejuvenated hot spa development since 1978, has selected and implemented Trintech's bank-accredited, PayWare Merchant, to process all its card payment transactions, including EMV Chip and PIN.
PAB Bankshares, Inc.
PAB Bankshares, Inc. Announces Second Quarter 2003 Earnings
VALDOSTA, Ga., July 25, 2003 (PRIMEZONE) -- PAB Bankshares, Inc. (AMEX:PAB), the holding company for The Park Avenue Bank of Valdosta, Georgia, announced preliminary earnings for the second quarter of 2003. The Company reported net income of $1.73 million, or $.18 per diluted share, for the quarter, a slight increase over the net income of $1.70 million, or $.18 per diluted share, earned during the second quarter of 2002. "The flat earnings growth is directly attributable to the decrease in our loan portfolio. Over the past eighteen months we have had to focus our resources on addressing regulatory and administrative matters. This has taken a toll on our efforts for new loan production, and this absence of loan production has had and will continue to have an impact on our ability to grow earnings," stated Michael E. Ricketson, President and Chief Executive Officer. "We are, however, optimistic about our future. Our balance sheet is strong, we are addressing our asset quality concerns, and we now have the pieces in place to grow our company. It will just take more time than we had originally estimated. The slow economy and the limited growth opportunities in our south Georgia markets are other factors that we are facing. Our future success depends on our ability to maintain good asset quality and expand our presence in growth markets as the opportunities arise," Ricketson added.